candesartan has been researched along with Cruveilhier-Baumgarten Syndrome in 3 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Alla, MD | 1 |
| Eid, EMM | 1 |
| Soliman, AIA | 1 |
| Elhawary, MA | 1 |
| Kilany, YF | 1 |
| Abd-Almonaem, G | 1 |
| Bayoumi, SS | 1 |
| Moursy, MRA | 1 |
| Al-Zaem, FAM | 1 |
| Kim, JH | 1 |
| Kim, JM | 1 |
| Cho, YZ | 1 |
| Na, JH | 1 |
| Kim, HS | 1 |
| Kim, HA | 1 |
| Kang, HW | 1 |
| Baik, SK | 1 |
| Kwon, SO | 1 |
| Cha, SH | 1 |
| Kim, YJ | 1 |
| Kim, MY | 1 |
| Heim, MH | 1 |
| Jacob, L | 1 |
| Beglinger, C | 1 |
3 trials available for candesartan and Cruveilhier-Baumgarten Syndrome
| Article | Year |
|---|---|
PORTAL HYPERTENSION TREATMENT WITH CANDESARTAN PLUS PROPRANOLOL FOR NINE MONTHS RESTORES NORMAL PORTAL CIRCULATION HEMODYNAMIC PATTERN.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Administration Schedule; Drug Ther | 2016 |
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure | 2014 |
The angiotensin II receptor antagonist candesartan is not effective in reducing portal hypertension in patients with cirrhosis.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hyperte | 2007 |